UniProt ID | GTPB1_HUMAN | |
---|---|---|
UniProt AC | O00178 | |
Protein Name | GTP-binding protein 1 | |
Gene Name | GTPBP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 669 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Promotes degradation of target mRNA species. Plays a role in the regulation of circadian mRNA stability. Binds GTP and has GTPase activity (By similarity).. | |
Protein Sequence | MATERSRSAMDSPVPASMFAPEPSSPGAARAAAAAARLHGGFDSDCSEDGEALNGEPELDLTSKLVLVSPTSEQYDSLLRQMWERMDEGCGETIYVIGQGSDGTEYGLSEADMEASYATVKSMAEQIEADVILLRERQEAGGRVRDYLVRKRVGDNDFLEVRVAVVGNVDAGKSTLLGVLTHGELDNGRGFARQKLFRHKHEIESGRTSSVGNDILGFDSEGNVVNKPDSHGGSLEWTKICEKSTKVITFIDLAGHEKYLKTTVFGMTGHLPDFCMLMVGSNAGIVGMTKEHLGLALALNVPVFVVVTKIDMCPANILQETLKLLQRLLKSPGCRKIPVLVQSKDDVIVTASNFSSERMCPIFQISNVTGENLDLLKMFLNLLSPRTSYREEEPAEFQIDDTYSVPGVGTVVSGTTLRGLIKLNDTLLLGPDPLGNFLSIAVKSIHRKRMPVKEVRGGQTASFALKKIKRSSIRKGMVMVSPRLNPQASWEFEAEILVLHHPTTISPRYQAMVHCGSIRQTATILSMDKDCLRTGDKATVHFRFIKTPEYLHIDQRLVFREGRTKAVGTITKLLQTTNNSPMNSKPQQIKMQSTKKGPLTKRDEGGPSGGPAVGAPPPGDEASSVGAGQPAASSNLQPQPKPSSGGRRRGGQRHKVKSQGACVTPASGC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MATERSRSAM -----CCCHHHHHCC | 30.54 | 26074081 | |
6 | Phosphorylation | --MATERSRSAMDSP --CCCHHHHHCCCCC | 25.10 | 21712546 | |
8 | Phosphorylation | MATERSRSAMDSPVP CCCHHHHHCCCCCCC | 29.23 | 29255136 | |
12 | Phosphorylation | RSRSAMDSPVPASMF HHHHCCCCCCCHHHC | 18.08 | 29255136 | |
17 | Phosphorylation | MDSPVPASMFAPEPS CCCCCCHHHCCCCCC | 14.36 | 23401153 | |
24 | Phosphorylation | SMFAPEPSSPGAARA HHCCCCCCCHHHHHH | 47.72 | 29255136 | |
25 | Phosphorylation | MFAPEPSSPGAARAA HCCCCCCCHHHHHHH | 37.76 | 29255136 | |
44 | Phosphorylation | RLHGGFDSDCSEDGE HHCCCCCCCCCCCCC | 37.95 | 26846344 | |
47 | Phosphorylation | GGFDSDCSEDGEALN CCCCCCCCCCCCHHC | 43.65 | 26846344 | |
62 | Phosphorylation | GEPELDLTSKLVLVS CCCCCCCCCEEEEEC | 24.39 | 30266825 | |
63 | Phosphorylation | EPELDLTSKLVLVSP CCCCCCCCEEEEECC | 31.15 | 30266825 | |
69 | Phosphorylation | TSKLVLVSPTSEQYD CCEEEEECCCHHHHH | 20.49 | 29255136 | |
71 | Phosphorylation | KLVLVSPTSEQYDSL EEEEECCCHHHHHHH | 37.07 | 29255136 | |
72 | Phosphorylation | LVLVSPTSEQYDSLL EEEECCCHHHHHHHH | 26.53 | 29255136 | |
77 | Phosphorylation | PTSEQYDSLLRQMWE CCHHHHHHHHHHHHH | 25.11 | 24719451 | |
101 | Phosphorylation | IYVIGQGSDGTEYGL EEEEEECCCCCCCCC | 25.61 | 23403867 | |
104 | Phosphorylation | IGQGSDGTEYGLSEA EEECCCCCCCCCCHH | 30.90 | 23403867 | |
109 | Phosphorylation | DGTEYGLSEADMEAS CCCCCCCCHHHHHHH | 26.78 | 23403867 | |
116 | Phosphorylation | SEADMEASYATVKSM CHHHHHHHHHHHHHH | 11.29 | 23403867 | |
119 | O-linked_Glycosylation | DMEASYATVKSMAEQ HHHHHHHHHHHHHHH | 21.89 | OGP | |
122 | O-linked_Glycosylation | ASYATVKSMAEQIEA HHHHHHHHHHHHHCH | 20.91 | OGP | |
174 | Phosphorylation | GNVDAGKSTLLGVLT ECCCCCCCEEEEEEC | 24.30 | - | |
175 | Phosphorylation | NVDAGKSTLLGVLTH CCCCCCCEEEEEECC | 29.50 | - | |
181 | Phosphorylation | STLLGVLTHGELDNG CEEEEEECCCCCCCC | 25.98 | - | |
205 | Phosphorylation | RHKHEIESGRTSSVG HCHHHHCCCCCCCCC | 38.96 | 21406692 | |
208 | Phosphorylation | HEIESGRTSSVGNDI HHHCCCCCCCCCCCC | 28.95 | 27251275 | |
209 | Phosphorylation | EIESGRTSSVGNDIL HHCCCCCCCCCCCCC | 22.97 | 27251275 | |
210 | Phosphorylation | IESGRTSSVGNDILG HCCCCCCCCCCCCCC | 33.17 | 27251275 | |
227 | Ubiquitination | SEGNVVNKPDSHGGS CCCCEECCCCCCCCC | 38.29 | 29967540 | |
239 | Ubiquitination | GGSLEWTKICEKSTK CCCCEEHEEECCCCC | 46.57 | 29967540 | |
258 | Acetylation | IDLAGHEKYLKTTVF EECCCCHHHHHHHHH | 50.65 | 19824831 | |
259 | Phosphorylation | DLAGHEKYLKTTVFG ECCCCHHHHHHHHHC | 15.50 | - | |
263 | Phosphorylation | HEKYLKTTVFGMTGH CHHHHHHHHHCCCCC | 16.55 | - | |
330 | Acetylation | KLLQRLLKSPGCRKI HHHHHHHCCCCCCCC | 60.23 | 25953088 | |
343 | Phosphorylation | KIPVLVQSKDDVIVT CCCEEEECCCCEEEE | 30.49 | 23663014 | |
363 | Ubiquitination | SERMCPIFQISNVTG CCCCCCEEEEECCCC | 2.97 | 24816145 | |
371 | Ubiquitination | QISNVTGENLDLLKM EEECCCCCCHHHHHH | 45.30 | 24816145 | |
384 | Phosphorylation | KMFLNLLSPRTSYRE HHHHHHHCCCCCCCC | 18.59 | 18669648 | |
433 | Ubiquitination | TLLLGPDPLGNFLSI EEEECCCCCHHHHHH | 45.35 | 24816145 | |
456 | Methylation | RMPVKEVRGGQTASF CCCCEEECCCCCHHH | 44.61 | - | |
460 | Phosphorylation | KEVRGGQTASFALKK EEECCCCCHHHHHHH | 27.78 | - | |
462 | Phosphorylation | VRGGQTASFALKKIK ECCCCCHHHHHHHHH | 17.91 | 27251275 | |
466 | Acetylation | QTASFALKKIKRSSI CCHHHHHHHHHHHHC | 49.36 | 25953088 | |
472 | Phosphorylation | LKKIKRSSIRKGMVM HHHHHHHHCCCCEEE | 30.37 | 24719451 | |
475 | Ubiquitination | IKRSSIRKGMVMVSP HHHHHCCCCEEEECC | 50.08 | 24816145 | |
481 | Phosphorylation | RKGMVMVSPRLNPQA CCCEEEECCCCCCCC | 6.04 | 21712546 | |
483 | Ubiquitination | GMVMVSPRLNPQASW CEEEECCCCCCCCCE | 39.32 | 24816145 | |
517 | Phosphorylation | QAMVHCGSIRQTATI HHHEECCCHHHHEEE | 21.71 | 28857561 | |
523 | Phosphorylation | GSIRQTATILSMDKD CCHHHHEEEEEECHH | 26.32 | - | |
556 | Methylation | EYLHIDQRLVFREGR CEECCCCEEEECCCC | 29.13 | - | |
565 | Ubiquitination | VFREGRTKAVGTITK EECCCCCCHHHHHHH | 39.45 | 29967540 | |
569 | Phosphorylation | GRTKAVGTITKLLQT CCCCHHHHHHHHHHH | 20.90 | - | |
576 | Phosphorylation | TITKLLQTTNNSPMN HHHHHHHHCCCCCCC | 31.31 | 30266825 | |
577 | Phosphorylation | ITKLLQTTNNSPMNS HHHHHHHCCCCCCCC | 21.31 | 30266825 | |
580 | Phosphorylation | LLQTTNNSPMNSKPQ HHHHCCCCCCCCCCC | 27.82 | 22167270 | |
584 | Phosphorylation | TNNSPMNSKPQQIKM CCCCCCCCCCCCCCC | 39.19 | 30266825 | |
585 | Ubiquitination | NNSPMNSKPQQIKMQ CCCCCCCCCCCCCCC | 41.67 | 32015554 | |
590 | Ubiquitination | NSKPQQIKMQSTKKG CCCCCCCCCCCCCCC | 26.92 | 29967540 | |
600 | Phosphorylation | STKKGPLTKRDEGGP CCCCCCCCCCCCCCC | 27.45 | 20860994 | |
623 | Phosphorylation | PPPGDEASSVGAGQP CCCCCCCCCCCCCCC | 24.41 | 30177828 | |
624 | Phosphorylation | PPGDEASSVGAGQPA CCCCCCCCCCCCCCC | 31.45 | 30177828 | |
633 | Phosphorylation | GAGQPAASSNLQPQP CCCCCCCCCCCCCCC | 23.12 | 30177828 | |
634 | Phosphorylation | AGQPAASSNLQPQPK CCCCCCCCCCCCCCC | 36.51 | 30177828 | |
643 | Phosphorylation | LQPQPKPSSGGRRRG CCCCCCCCCCCCCCC | 47.98 | 30177828 | |
644 | Phosphorylation | QPQPKPSSGGRRRGG CCCCCCCCCCCCCCC | 54.52 | 30177828 | |
658 | Phosphorylation | GQRHKVKSQGACVTP CCCCCCCCCCCEECC | 36.51 | 28450419 | |
664 | Phosphorylation | KSQGACVTPASGC-- CCCCCEECCCCCC-- | 17.02 | 25850435 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GTPB1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GTPB1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GTPB1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
IF2G_HUMAN | EIF2S3 | physical | 26344197 | |
PRC1_HUMAN | PRC1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND SER-47, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-24; SER-25;SER-44; SER-47; SER-580 AND SER-584, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25; SER-44; SER-47 ANDSER-580, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND SER-47, AND MASSSPECTROMETRY. |